Patents Examined by Ardin Marschel
-
Patent number: 9404147Abstract: The invention provides compositions and methods for making closed nucleic acid structures in which one or both strands are continuous. The closed nucleic acid structures can be used as sequencing templates among other applications.Type: GrantFiled: December 19, 2012Date of Patent: August 2, 2016Assignee: GEN-PROBE INCORPORATEDInventors: Norman C. Nelson, Jijumon Chelliserry
-
Patent number: 9309561Abstract: Extended rhodamine compounds exhibiting favorable fluorescence characteristics having the structure are disclosed. In addition, novel intermediates for synthesis of these dyes are disclosed, such intermediates having the structure In addition, methods of making and using the dyes as fluorescent labels are disclosed.Type: GrantFiled: December 5, 2013Date of Patent: April 12, 2016Assignee: Applied Biosystems, LLCInventors: Joe Y. L. Lam, Scott C. Benson, Steven M. Menchen
-
Patent number: 9284602Abstract: Provided herein are primers and primer systems having improved specificity and kinetics over existing primers, and methods of use thereof.Type: GrantFiled: October 27, 2011Date of Patent: March 15, 2016Assignee: President and Fellows of Harvard CollegeInventors: David Yu Zhang, Peng Yin
-
Patent number: 9267111Abstract: Described herein are methods of treating a female subject in need of in vitro fertilization to become pregnant by detecting a loss of non-atretic follicles in the female subject and providing in vitro fertilization to the female subject.Type: GrantFiled: January 14, 2011Date of Patent: February 23, 2016Assignee: The General Hospital CorporationInventors: Jonathan L. Tilly, Joshua Johnson
-
Patent number: 9261518Abstract: The application relates to a method for producing a medical bioprosthesis that can be transplanted in a patient and comprises substances from animal tissue, said method comprising a step during which a bioprosthesis is positively selected for implantation in the body of said patient when (i) the phenotype in the ABO/ABH system of said bioprosthesis is compatible with (ii) the phenotype in the ABO/ABH system of said patient.Type: GrantFiled: October 13, 2010Date of Patent: February 16, 2016Inventor: Olivier Schussler
-
Patent number: 9255293Abstract: The invention provides efficient methods of preparing a target nucleic acid in a form suitable for sequencing. The methods are particularly amenable for preparing high quality nucleic acids for massively parallel sequencing. The methods involve capturing a target nucleic acid from a sample and PCR amplification of the target nucleic acid. The target nucleic acid is captured by binding to a capture probe, which in turn binds to an immobilized probe. The immobilized probe is typically immobilized via a magnetic bead. The captured target nucleic acid is PCR amplified by thermocycling without prior dissociation of the target nucleic acid from the beads. The efficiency of the method lies in part in that both the capture and amplification steps are performed in a single vessel. The amplified nucleic acid can then be sequenced.Type: GrantFiled: November 1, 2011Date of Patent: February 9, 2016Assignee: GEN-PROBE INCORPORATEDInventors: Reinhold Pollner, Shyun-Shyun Lee
-
Patent number: 9249457Abstract: The purpose of the subject invention is to provide a method of manufacturing a mixture of amplified double-stranded nucleic acids comprising unknown sequence including the complete 5? end sequence. A method of manufacturing a mixture of amplified double-stranded nucleic acids comprising: (a) preparing a single-stranded nucleic acid comprising a single-stranded adapter 1, a single-stranded nucleic acid fragment and a single-stranded adapter 2, and (b) conducting PCR with said single-stranded nucleic acid prepared in step (a), a primer 1, and a primer 2 to amplify double-stranded nucleic acids.Type: GrantFiled: June 18, 2009Date of Patent: February 2, 2016Assignee: RikenInventors: Piero Carninci, Charles Plessy, Roberto Simone
-
Patent number: 9243272Abstract: Disclosed is a thermostable DNA polymerase preparation which can illimitably reduce the risk of false positivity in the detection of a subject microorganism utilizing a gene amplification reaction and therefore enables the selective amplification of DNA for detecting the subject microorganism even when the amount of the subject microorganism is small and therefore the amount of DNA collected therefrom is extremely small, and can be produced at a reduced cost. Also disclosed is a method for quantifying or quantifying/identifying a subject organism to be detected rapidly, conveniently and with high sensitivity using the preparation of the present invention.Type: GrantFiled: January 15, 2010Date of Patent: January 26, 2016Assignees: HOKKAIDO MITSUI CHEMICALS INC., NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMAInventors: Homare Tabata, Hiroshi Minami, Hideki Niimi, Isao Kitajima, Tomohiro Ueno, Shiroh Hayashi, Masashi Mori
-
Patent number: 9217177Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: GrantFiled: January 9, 2013Date of Patent: December 22, 2015Assignee: APPLIED BIOSYSTEMS, LLCInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Patent number: 9212387Abstract: Provided is a detection kit for detecting target genes of miRNA. Also provided is a method of detecting target genes of miRNA in a simple manner without the need for performing a transfection operation of a gene into cells via a vector. The detection kit is a detection kit for target genes of microRNA, including a cell extraction reagent, and a labeling reagent for microRNA or labeled microRNA, and further including a reaction reagent for the labeling substance for microRNA. mRNA corresponding to target genes of miRNA can be easily pulled down by producing a cell extract under mild conditions, adding labeled miRNA to the cell extract, and recovering the labeling substance. cDNA is produced from the pulled down mRNA to detect target genes of miRNA.Type: GrantFiled: June 15, 2011Date of Patent: December 15, 2015Assignee: National University Corporation Okayama UniversityInventors: Mamoru Ouchida, Sachio Ito
-
Patent number: 9207690Abstract: A processing apparatus includes a carrier receiving region configured to receive a sample carrier with at least one channel that carries at least one sample. The apparatus further includes a thermal control device configured to thermal cycle the sample carrier when the sample carrier is installed in the carrier receiving region, thereby thermal cycling the sample carried therein. The apparatus further includes a thermal control system configured to control the temperature control device based on a predetermined set of target sample temperatures and a temperature map, which maps the predetermined set of target sample temperatures to a set of temperatures of the temperature control device. The set of temperatures of the temperature control device is different from the predetermined set of target sample temperatures, and the set of temperatures of the temperature control device thermal cycle the sample carrier with the temperatures of the predetermined set of target sample temperatures.Type: GrantFiled: September 23, 2011Date of Patent: December 8, 2015Assignee: Analogic CorporationInventor: Mark Tverskoy
-
Patent number: 9200291Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to identify desirable phenotypic changes that disrupt or alter existing genetic or biochemical mechanisms or pathways, thus creating novel characteristics of the transformed organism. Methods for using the compositions for increasing diversity within populations of organisms are also presented.Type: GrantFiled: December 19, 2013Date of Patent: December 1, 2015Inventor: Helge Zieler
-
Patent number: 9193993Abstract: The invention is directed to a method for isothermally amplifying a DNA sequence involving hybridizing a destabilizing DNA template to complementary nucleotide fragments to form a first nicked duplex; ligating the first nicked duplex to form a product duplex comprising the DNA sequence and the template, wherein the product duplex is capable of dissociating to release the DNA sequence and the template; and repeating these steps to generate multiple copies of the template and the DNA sequence. Further, the method may also involve hybridizing the DNA sequence to complementary destabilizing fragments or probes to form a second nicked duplex; ligating the second nicked duplex to form the product duplex comprising the DNA sequence and the template, wherein the product duplex dissociates to release the DNA sequence and the template; and repeating these steps to generate multiple copies of the template and the DNA sequence.Type: GrantFiled: March 7, 2013Date of Patent: November 24, 2015Inventors: Julianne M Gibbs-Davis, Rosalie Dawn McKay, Yimeng Li, Jade Lam, Abu Kausar, Catherine Jennifer Mitran
-
Patent number: 9194006Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.Type: GrantFiled: July 6, 2012Date of Patent: November 24, 2015Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Jules Chen, Michelle M. Tabb, Michael Aye, Emberlee Eleazar
-
Patent number: 9194861Abstract: System, including methods, apparatus, compositions, and kits, for the mixing of small volumes of fluid by coalescence of multiple emulsions.Type: GrantFiled: August 24, 2010Date of Patent: November 24, 2015Assignee: Bio-Rad Laboratories, Inc.Inventors: Benjamin J. Hindson, Billy W. Colston, Jr., Kevin D. Ness, Donald A. Masquelier
-
Patent number: 9193997Abstract: Methods are provided for the detection and analysis of clonality in a cell population, where parallel sequencing is applied to a nucleic acid sample obtained from the cell population, optionally a population of lymphocytes. Replicate samples are amplified, and sequenced, where identification of coincident sequences in two or more replicates is indicative of clonal expansion.Type: GrantFiled: December 15, 2011Date of Patent: November 24, 2015Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Andrew Fire, Scott D. Boyd, Jason Merker, Kyunga Seo, Eleanor L. Marshall
-
Patent number: 9187781Abstract: The present invention is to provide a method for identifying a polymorphism. The method includes performing a nucleic acid chain extension reaction and identifying the polymorphism of the nucleic acid contained in the test nucleic acid sample. The extension reaction is conducted with use of a nucleic acid in a test nucleic acid sample as a template, a type I detection primer which hybridizes with a region including the polymorphic site of a nucleic acid whose polymorphic site nucleotide sequence consisting of a first nucleotide sequence, and a polymerase. The reaction is conducted with the presence of an inhibitory oligonucleotide, which hybridizes with the type I detection primer. The region of the type I detection primer to hybridize with the inhibitory oligonucleotide is located on the 5? side of the polymorphism detection site of the type I detection primer to hybridize with the polymorphic site.Type: GrantFiled: April 13, 2010Date of Patent: November 17, 2015Assignee: OLYMPUS CORPORATIONInventor: Tetsuya Tanabe
-
Patent number: 9175349Abstract: The present invention provides biomarkers for the diagnosis and prognosis of endometriosis. Generally, the methods of this invention find use in diagnosing or for providing a prognosis for endometriosis by detecting the expression levels of biomarkers, which are differentially expressed (up- or down-regulated) in endometrial cells from a patient with endometriosis. Similarly, these markers can be used to diagnose reduced fertility in a patient with endometriosis or to provide a prognosis for a fertility trial in a patient suffering from endometriosis. The present invention also provides methods of identifying a compound for treating or preventing endometriosis. Finally, the present invention provides kits for the diagnosis or prognosis of endometriosis.Type: GrantFiled: October 1, 2013Date of Patent: November 3, 2015Assignee: The Regents of the University of CaliforniaInventor: Linda C. Giudice
-
Patent number: 9168531Abstract: A thermal cycler for a microfluidic device includes a controller operable to provide a series of electrical signals, a heat sink, and a heating element in thermal communication with the heat sink and operable to receive the series of electrical signals from the controller. The thermal cycler also includes a thermal chuck in thermal communication with the heating element. The thermal chuck comprises a heating surface operable to make thermal contact with the microfluidic device. The heating surface is characterized by a temperature ramp rate between 2.5 degrees Celsius per second and 5.5 degrees Celsius per second and a temperature difference between a first portion of the heating surface supporting a first portion of the microfluidic device and a second portion of the heating surface supporting a second portion of the microfluidic device is less than 0.25° C.Type: GrantFiled: March 26, 2012Date of Patent: October 27, 2015Assignee: FLUIDIGM CORPORATIONInventors: Jake Kimball, Brandon Ripley, Gang Sun, Dominique Toppani, Myo Thu Maung
-
Patent number: 9163277Abstract: Microfluidic devices of the present disclosure relate to quick and inexpensive microfluidic manipulation/handling. A number of channels may be provided for supply of fluid ingredients to a number of cavities. A separating material may provide fluid separation between a number of cavities, such as corresponding cavities of a reaction chamber. Once the cavities are supplied with fluid ingredient, channels connecting the cavities may be sealed off; that is, the cavities may be subject to fluid isolation. In some embodiments, a sealing material may be compressed so as to deform into the channels obstructing fluid flow. The separating material may be manipulated so that the initial fluid separation between cavities is removed. Removal of this fluid separation subsequently permits mixing of fluid ingredient(s) contained within previously separated cavities. In some embodiments, the fluid separation may be removed by heating or dissolving portions of the separating material.Type: GrantFiled: March 14, 2013Date of Patent: October 20, 2015Assignee: Formulatrix, Inc.Inventors: Kabir James Yamana, Sean Yamana-Hayes